About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
Investment stages
  • Series A
  • Series B
Industries
  • Pharmaceuticals
  • Drug Delivery
  • Health & Hospital Services
  • Digital Health
  • Health It
About
Amgen Ventures is the venture capital arm of Amgen Inc., investing in earlystage biotechnology and pharmaceutical companies to drive innovation and support the development of new therapies and treatments.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Amgen Focuses on investing in innovative biotechnology and pharmaceutical companies that align with Amgen’s strategic interests and advance medical science.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

David M. Reese: EVP of Research and Development

Shannon J. Klinger: EVP and Chief Legal Officer

Jay R. Lichter: Managing Partner

Portfolio

Agenus

Editas Medicine

Imara

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp